EcoDrugPlus

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSNGAG00000013835
Gene Symbol: MIF
3 Cross references
218 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSNGAG00000006916
Gene Symbol: MST1R
3 Cross references
266 Possible Orthologues:

Maltase-Glucoamylase, Intestinal

Ensembl ID : ENSNGAG00000010341
Gene Symbol: LOC103726140
2 Cross references
312 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSNGAG00000012323
Gene Symbol: MMP12
3 Cross references
550 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSNGAG00000013401
Gene Symbol: MMP13
3 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSNGAG00000011134
Gene Symbol: MMP14
3 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSNGAG00000020203
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSNGAG00000008287
Gene Symbol: MMP3
3 Cross references
493 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSNGAG00000000983
Gene Symbol: MMP7
3 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSNGAG00000009311
Gene Symbol: MMP8
3 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSNGAG00000007661
Gene Symbol: MMP9
3 Cross references
214 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSNGAG00000024031
Gene Symbol: MTOR
3 Cross references
214 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).